Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I

Nature Genetics
Markus GrompeM Finegold

Abstract

Hereditary tyrosinaemia type I, a severe autosomal recessive metabolic disease, affects the liver and kidneys and is caused by deficiency of fumarylacetoacetate hydrolase (FAH). Mice homozygous for a FAH gene disruption have a neonatal lethal phenotype caused by liver dysfunction and do not represent an adequate model of the human disease. Here we demonstrate that treatment of affected animals with 2-(2-nitro-4-trifluoro-methylbenzyol)-1,3-cyclohexanedione abolished neonatal lethality, corrected liver function and partially normalized the altered expression pattern of hepatic mRNAs. The prolonged lifespan of affected animals resulted in a phenotype analogous to human tyrosinaemia type I including hepatocellular carcinoma. The adult FAH-/- mouse will serve as useful model for studies of the pathophysiology and treatment of hereditary tyrosinaemia type I as well as hepatic cancer.

Associated Clinical Trials

References

Jul 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·K S ZaretS Gluecksohn-Waelsch
Aug 1, 1992·Biochemical Medicine and Metabolic Biology·M Grompe, M al-Dhalimy
Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·C S GiomettiS Gluecksohn-Waelsch
Feb 15, 1990·The New England Journal of Medicine·G MitchellA Larbrisseau
Jan 1, 1989·Journal of Pediatric Surgery·M KalayogluF O Belzer
Dec 1, 1989·Genes & Development·S L McKnightS Gluecksohn-Waelsch
Oct 1, 1989·Journal of Pediatric Surgery·H BlanchardJ Adelson
Jun 20, 1987·Lancet·M A EdwardsG Rylance
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J LemR E Fournier
Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D DeFrancoS Gluecksohn-Waelsch
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D S LooseS Gluecksohn-Waelsch
Jul 24, 1987·Science·G VeresC T Caskey
Apr 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J M Sala-TrepatS Gluecksohn-Waelsch
Feb 1, 1986·Scandinavian Journal of Clinical and Laboratory Investigation·M E MartinezJ Quero
Mar 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·S Gluecksohn-WaelschC F Cori
Jun 23, 1993·Annals of the New York Academy of Sciences·D W NebertV Vasiliou

❮ Previous
Next ❯

Citations

Jul 20, 2002·Cell Biology International·Lene AarenstrupKarsten Kristiansen
Feb 22, 2011·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Brian A Yeagy, Stephanie Cherqui
Jun 10, 2006·Journal of Inherited Metabolic Disease·Markus Grompe
May 25, 2010·Journal of Inherited Metabolic Disease·Cary O Harding, K M Gibson
Aug 12, 1999·European Journal of Pharmacology·U Rudolph, H Möhler
Mar 23, 2000·Journal of Hepatology·S S GhoshJ R Chowdhury
Apr 12, 2002·Journal of Hepatology·David A Shafritz, Mariana D Dabeva
Dec 2, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Xin Cheng, Paul Gadue
Aug 9, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nicole K PaulkMarkus Grompe
Sep 25, 2012·Nature Biotechnology·Junji KomoriEric Lagasse
Aug 1, 2007·Nature Biotechnology·Hisaya AzumaMarkus Grompe
Mar 1, 1996·Nature Genetics·J M Wilson
Sep 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Neil D Theise
Aug 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Xin WangMarkus Grompe
Mar 21, 1998·Human Gene Therapy·K OverturfM Grompe
Aug 14, 1998·Journal of Pediatric Gastroenterology and Nutrition·D A Kelly
Aug 2, 2002·Journal of Pediatric Gastroenterology and Nutrition·David H Perlmutter
Jun 16, 2010·Journal of Gastroenterology and Hepatology·Elke EggenhoferFelix C Popp
Aug 26, 2004·Kidney International·Marjanka C LuijerinkInge E T van den Berg
Jun 8, 2002·Molecular and Cellular Biology·José Manuel Fernández-CañónMarkus Grompe
Apr 8, 1999·Archives of Disease in Childhood·A BakerN Heaton
Nov 1, 2001·Annual Review of Cell and Developmental Biology·I L WeissmanF Gage
Feb 25, 2010·The Journal of Clinical Investigation·Ype P de JongAlexander Ploss
Sep 22, 2012·The Journal of Clinical Investigation·Ashley M VaughanStefan H I Kappe
Feb 24, 2006·Pediatric Research·Saskia M M JacobsInge E T van den Berg
Feb 21, 2009·PLoS Genetics·Andrew W DuncanMarkus Grompe
Oct 25, 2013·PloS One·Abeba TesfayeStephen M Feinstone
Mar 7, 2008·The American Journal of Pathology·Fabio MarongiuEzio Laconi
May 10, 2012·Future Microbiology·Ashley M VaughanSebastian A Mikolajczak
May 24, 2014·Cell Death & Disease·D XiangY-P Hu
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·M J Prieto-Alamo, F Laval
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·S KuboF Endo
Oct 16, 1999·Proceedings of the National Academy of Sciences of the United States of America·K ManningM Grompe
Sep 19, 2014·Science Translational Medicine·Ype P de JongAlexander Ploss
Sep 5, 2001·Current Opinion in Genetics & Development·J M Slack, D Tosh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.